Douglas K. Bratton, 10% Owner at Denali Therapeutics Inc. (DNLI), bought 275,000 shares at $18.00 ($5.0M) on 2017-12-12, disclosed to the SEC on 2017-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| JUNO | SELL | 2015-07-02 | $2.2M | — | Filing → |
| JUNO | SELL | 2015-06-25 | $13.8M | — | Filing → |
| JUNO | BUY | 2014-12-24 | $15.0M | — | Filing → |